Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, ...

New research shows autism rates in women may match men by adulthood, revealing diagnostic bias and the urgent need to update ...

Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers-Delivering Risk Prediction Where Proteomics Falls ShortMORRISVILLE, N.C., Feb. 17, 2026 /PRNewswire/ -- Metabolon ...

For some, the moment the perpetrator of Canada’s worst school shooting in 30 years was described as a “female in a dress”, alarm bells started ringing. Speculation only intensified when a local ...

The Netherlands is one of Europe’s most active places for AI talent, according to research from Dealroom.co published with ...

The belief that soothing sounds can calm the mind is ancient. Today, it has evolved into ‘sound healing’ therapy on the ...

This is the kind of place where South Carolinians make pilgrimages from every corner of the state, where the phrase “all you can eat” isn’t a challenge but a warm invitation to experience Southern ...

Kingdom Come State Park in Cumberland is exactly that kind of place, where the main requirement is showing up and letting the ...

MS affects over 150,000 people in the UK, with tens of thousands living with progressive MS. The condition affects the brain ...

Military service members and veterans frequently experience post-traumatic stress disorder (PTSD), which is linked to a range of psychological challenges and adverse effects. Cognitive-behavioral ...

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...